Scientists Begin Testing Zika Vaccine in Humans
On Monday scientists began a Phase 1 human clinical trial to test safety and immunogenicity, or the ability to provoke an immune response, of the Zika purified inactivated virus (ZPIV) vaccine. The study, supported by the National Institutes of ...